Item 16. FORM 10-K SUMMARY

2K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



	THE CLOROX COMPANY

Date: August 13, 2019	By:	/s/ Benno Dorer
		Benno Dorer
		Chair and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



Signature	Title	Date
/s/ A. Banse	Director	August 13, 2019
A. Banse
/s/ R. H. Carmona	Director	August 13, 2019
R. H. Carmona
/s/ S. C. Fleischer	Director	August 13, 2019
S. C. Fleischer
/s/ E. Lee	Director	August 13, 2019
E. Lee
/s/ A. D. D. Mackay	Director	August 13, 2019
A. D. D. Mackay
/s/ R. W. Matschullat	Director	August 13, 2019
R. W. Matschullat
/s/ M. J. Shattock	Director	August 13, 2019
M. J. Shattock
/s/ P. Thomas-Graham	Director	August 13, 2019
P. Thomas-Graham
/s/ C. M. Ticknor	Director	August 13, 2019
C. M. Ticknor
/s/ R. J. Weiner	Director	August 13, 2019
R. J. Weiner
/s/ C. J. Williams	Director	August 13, 2019
C. J. Williams
/s/ B. Dorer	Chair and Chief Executive Officer (Principal Executive Officer)	August 13, 2019
B. Dorer
/s/ K. B. Jacobsen	Executive Vice President – Chief Financial Officer (Principal Financial Officer)	August 13, 2019
K. B. Jacobsen
/s/ J. R. Baker	Vice President – Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)	August 13, 2019
J. R. Baker

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES